Bain Capital Public Equity Management, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
| Filed | Shares | Percentage | |
|---|---|---|---|
| Affimed N.V. | February 14, 2019 | 2,362,813 | 3.8% |
| IMMUNE DESIGN CORP. | February 14, 2019 | 892,061 | 1.8% |
| REVA Medical, Inc. | February 14, 2019 | 296,502,220 | 7.2% |
| MULESOFT, INC | February 14, 2018 | 1,404,025 | 1.9% |
| CONCERT PHARMACEUTICALS, INC. | February 28, 2014 | 1,147,833 | 6.7% |
| IDENIX PHARMACEUTICALS INC | February 12, 2014 | 13,115,858 | 9.8% |
| NORTHSTAR REALTY FINANCE CORP. | February 12, 2014 | 7,657,781 | 2.6% |
| PORTOLA PHARMACEUTICALS INC | February 12, 2014 | 400,000 | 1.0% |
| Dicerna Pharmaceuticals Inc | February 10, 2014 | 1,337,000 | 8.0% |
| RingCentral Inc | February 07, 2014 | 471,073 | 5.5% |